Evidence map›Paper›PMID 26359153›Full record

ArticleAJNR. American journal of neuroradiology2015

Longitudinal Study of Gray Matter Changes in Parkinson Disease.

X Jia, P Liang, Y Li, L Shi, D Wang, K Li

Open access · hybridAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Learning Phenotypic Associations for Parkinson's Disease with Longitudinal Clinical Records.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

X JiaFrom the Department of Radiology (X.J., P.L., Y.L., K.L.), Xuanwu Hospital, Capital Medical University, Beijing, China Beijing Key Laboratory of MRI and Brain Informatics (X.J., P.L., Y.L., K.L.), Beijing, China.
P LiangFrom the Department of Radiology (X.J., P.L., Y.L., K.L.), Xuanwu Hospital, Capital Medical University, Beijing, China Beijing Key Laboratory of MRI and Brain Informatics (X.J., P.L., Y.L., K.L.), Beijing, China.
Y LiFrom the Department of Radiology (X.J., P.L., Y.L., K.L.), Xuanwu Hospital, Capital Medical University, Beijing, China Beijing Key Laboratory of MRI and Brain Informatics (X.J., P.L., Y.L., K.L.), Beijing, China.
L ShiDepartment of Imaging and Interventional Radiology (L.S., D.W.), The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
D WangDepartment of Imaging and Interventional Radiology (L.S., D.W.), The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
K LiFrom the Department of Radiology (X.J., P.L., Y.L., K.L.), Xuanwu Hospital, Capital Medical University, Beijing, China Beijing Key Laboratory of MRI and Brain Informatics (X.J., P.L., Y.L., K.L.), Beijing, China cjr.likuncheng@vip.163.com.
Chinese Institute for Brain Research · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe pathology of Parkinson disease leads to morphological brain volume changes. So far, the progressive gray matter volume change across time specific to patients with Parkinson disease compared controls remains unclear. Our aim was to investigate the pattern of gray matter changes in patients with Parkinson disease and to explore the progressive gray matter volume change specific to patients with Parkinson disease with disease progression by using voxel-based morphometry analysis. MATERIALS AND

methodsLongitudinal cognitive assessment and structural MR imaging of 89 patients with Parkinson disease (62 men) and 55 healthy controls (33 men) were from the Parkinson's Progression Markers Initiative data base, including the initial baseline and 12-month follow-up data. Two-way analysis of covariance was performed with covariates of age, sex, years of education, imaging data from multiple centers, and total intracranial volume by using Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra tool from SPM8 software.

resultsGray matter volume changes for patients with Parkinson disease were detected with decreased gray matter volume in the frontotemporoparietal areas and the bilateral caudate, with increased gray matter volume in the bilateral limbic/paralimbic areas, medial globus pallidus/putamen, and the right occipital cortex compared with healthy controls. Progressive gray matter volume decrease in the bilateral caudate was found for both patients with Parkinson disease and healthy controls, and this caudate volume was positively associated with cognitive ability for both groups. The progressive gray matter volume increase specific to the patients with Parkinson disease was identified close to the left ventral lateral nucleus of thalamus, and a positive relationship was found between the thalamic volume and the tremor scores in a subgroup with tremor-dominant patients with Parkinson disease.

conclusionsThe observed progressive changes in gray matter volume in Parkinson disease may provide new insights into the neurodegenerative process. The current findings suggest that the caudate volume loss may contribute to cognitive decline in patients with Parkinson disease and the progressive thalamus enlargement may have relevance to tremor severity in Parkinson disease.

Indexed as

AdultAgedBrainFemaleGray MatterHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedParkinson Disease

Identifiers

PMID26359153
PMCPMC7964292
OpenAlexW1943406647

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.